Facephi Biometria, S.A.
EPA:ALPHI.PA
1.58 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 30.087 | 22.283 | 13.162 | 7.266 | 8.195 | 4.481 | 2.701 | 2.008 | 0.407 | 0.032 | 0.009 |
| Cost of Revenue
| 3.425 | -0.633 | -0.298 | 0.293 | 0.501 | -0.363 | -0.348 | -0.303 | -0.307 | -0.329 | -0.32 |
| Gross Profit
| 26.662 | 22.917 | 13.459 | 6.973 | 7.694 | 4.844 | 3.049 | 2.311 | 0.715 | 0.362 | 0.329 |
| Gross Profit Ratio
| 0.886 | 1.028 | 1.023 | 0.96 | 0.939 | 1.081 | 1.129 | 1.151 | 1.754 | 11.203 | 38.127 |
| Reseach & Development Expenses
| 0.005 | 0 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0.039 | 0.08 | 0.162 |
| General & Administrative Expenses
| -15.399 | 4.839 | 3.974 | 2.024 | 1.8 | 3.97 | 2.57 | 1.373 | 0.04 | 0.231 | 0.013 |
| Selling & Marketing Expenses
| 1.224 | 1.023 | 0.691 | 0.216 | 0.323 | 0.388 | 0.389 | 0.216 | 0.023 | 0.019 | 0 |
| SG&A
| -15.399 | 5.862 | 4.665 | 2.241 | 2.124 | 4.358 | 2.959 | 1.59 | 0.064 | 0.25 | 0.013 |
| Other Expenses
| 15.399 | 0.015 | -0.02 | -0.001 | 0.008 | 0.009 | -0 | -0.011 | 0 | 0 | 0 |
| Operating Expenses
| 31.283 | 20.333 | 13.871 | 6.852 | 5.007 | 6.387 | 4.129 | 4.199 | 1.473 | 1.365 | 0.671 |
| Operating Income
| 30.087 | 1.746 | -0.602 | -0.365 | 1.93 | 0.914 | 0.566 | -0.031 | -0.758 | -1.003 | -0.342 |
| Operating Income Ratio
| 1 | 0.078 | -0.046 | -0.05 | 0.236 | 0.204 | 0.21 | -0.016 | -1.861 | -31.051 | -39.692 |
| Total Other Income Expenses Net
| -30.087 | -0.721 | -0.252 | -1.637 | -0.212 | -0.061 | -0.093 | -0.032 | -0.036 | -0.033 | -0.007 |
| Income Before Tax
| -7.055 | 1.026 | -0.853 | -2.002 | 1.718 | 0.853 | 0.473 | -0.064 | -0.794 | -1.035 | -0.35 |
| Income Before Tax Ratio
| -0.234 | 0.046 | -0.065 | -0.275 | 0.21 | 0.19 | 0.175 | -0.032 | -1.948 | -32.063 | -40.561 |
| Income Tax Expense
| 2.746 | -0.081 | -0.299 | -0.147 | 0.43 | -0.315 | 0.108 | -0.012 | 0 | 0.024 | -0.051 |
| Net Income
| -4.31 | 1.107 | -0.554 | -1.855 | 1.288 | 1.167 | 0.365 | -0.064 | -0.794 | -1.059 | -0.299 |
| Net Income Ratio
| -0.143 | 0.05 | -0.042 | -0.255 | 0.157 | 0.261 | 0.135 | -0.032 | -1.948 | -32.803 | -34.668 |
| EPS
| -0.2 | 0.064 | -0.037 | -0.13 | 0.096 | 0.089 | 0.028 | -0.005 | -0.067 | -0.11 | -0.032 |
| EPS Diluted
| -0.2 | 0.064 | -0.037 | -0.13 | 0.096 | 0.089 | 0.028 | -0.005 | -0.067 | -0.11 | -0.032 |
| EBITDA
| 30.087 | 4.823 | 1.076 | 0.578 | 2.988 | 1.274 | 0.892 | 0.183 | -0.595 | -0.987 | -0.34 |
| EBITDA Ratio
| 1 | 0.216 | 0.082 | 0.079 | 0.365 | 0.284 | 0.33 | 0.091 | -1.461 | -30.561 | -39.464 |